Literature DB >> 19553587

Lack of heteroresistance among Staphylococcus aureus isolates with vancomycin MICs of 2 micrograms per milliliter by automated testing.

Sarah W Satola, Angela M Caliendo, Monica M Farley, Jean B Patel, Eileen M Burd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19553587      PMCID： PMC2725667          DOI： 10.1128/JCM.01184-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  3 in total

1.  A microdilution plating method for population analysis of antibiotic-resistant staphylococci.

Authors:  R F Pfeltz; J L Schmidt; B J Wilkinson
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

2.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

3.  A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors:  M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790
  3 in total
  7 in total

1.  Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.

Authors:  Sarah W Satola; Monica M Farley; Karen F Anderson; Jean B Patel
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

2.  Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Authors:  Sandra S Richter; Sarah W Satola; Emily K Crispell; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Andrew J Costello; Daniel J Diekema; Gary V Doern
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

3.  Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype.

Authors:  S W Satola; F C Lessa; S M Ray; S N Bulens; R Lynfield; W Schaffner; G Dumyati; J Nadle; J B Patel
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

4.  Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Authors:  Sandra S Richter; Daniel J Diekema; Kristopher P Heilmann; Cassie L Dohrn; Emily K Crispell; Fathollah Riahi; Jennifer S McDanel; Sarah W Satola; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

5.  Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.

Authors:  Md Tauqeer Alam; Robert A Petit; Emily K Crispell; Timothy A Thornton; Karen N Conneely; Yunxuan Jiang; Sarah W Satola; Timothy D Read
Journal:  Genome Biol Evol       Date:  2014-04-30       Impact factor: 3.416

6.  Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA).

Authors:  Michelle Su; Michelle H Davis; Jessica Peterson; Claudia Solis-Lemus; Sarah W Satola; Timothy D Read
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 3.061

7.  Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital.

Authors:  Andreia Paredes Damasco; Thaina Miranda da Costa; Priscylla Guimarães Migueres Morgado; Lorrayne Cardoso Guimarães; Fernanda Sampaio Cavalcante; Simone Aranha Nouér; Kátia Regina Netto Dos Santos
Journal:  Braz J Infect Dis       Date:  2019-04-24       Impact factor: 3.257
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.